Single-cell resolution imaging of retinal ganglion cell apoptosis in vivo using a cell-penetrating caspase-activatable peptide probe.

Peptide probes for imaging retinal ganglion cell (RGC) apoptosis consist of a cell-penetrating peptide targeting moiety and a fluorophore-quencher pair flanking an effector caspase consensus sequence. Using ex vivo fluorescence imaging, we previously validated the capacity of these probes to identif...

Full description

Saved in:
Bibliographic Details
Main Authors: Xudong Qiu, James R Johnson, Bradley S Wilson, Seth T Gammon, David Piwnica-Worms, Edward M Barnett
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0088855&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849720450657026048
author Xudong Qiu
James R Johnson
Bradley S Wilson
Seth T Gammon
David Piwnica-Worms
Edward M Barnett
author_facet Xudong Qiu
James R Johnson
Bradley S Wilson
Seth T Gammon
David Piwnica-Worms
Edward M Barnett
author_sort Xudong Qiu
collection DOAJ
description Peptide probes for imaging retinal ganglion cell (RGC) apoptosis consist of a cell-penetrating peptide targeting moiety and a fluorophore-quencher pair flanking an effector caspase consensus sequence. Using ex vivo fluorescence imaging, we previously validated the capacity of these probes to identify apoptotic RGCs in cell culture and in an in vivo rat model of N-methyl- D-aspartate (NMDA)-induced neurotoxicity. Herein, using TcapQ488, a new probe designed and synthesized for compatibility with clinically-relevant imaging instruments, and real time imaging of a live rat RGC degeneration model, we fully characterized time- and dose-dependent probe activation, signal-to-noise ratios, and probe safety profiles in vivo. Adult rats received intravitreal injections of four NMDA concentrations followed by varying TcapQ488 doses. Fluorescence fundus imaging was performed sequentially in vivo using a confocal scanning laser ophthalmoscope and individual RGCs displaying activated probe were counted and analyzed. Rats also underwent electroretinography following intravitreal injection of probe. In vivo fluorescence fundus imaging revealed distinct single-cell probe activation as an indicator of RGC apoptosis induced by intravitreal NMDA injection that corresponded to the identical cells observed in retinal flat mounts of the same eye. Peak activation of probe in vivo was detected 12 hours post probe injection. Detectable fluorescent RGCs increased with increasing NMDA concentration; sensitivity of detection generally increased with increasing TcapQ488 dose until saturating at 0.387 nmol. Electroretinography following intravitreal injections of TcapQ488 showed no significant difference compared with control injections. We optimized the signal-to-noise ratio of a caspase-activatable cell penetrating peptide probe for quantitative non-invasive detection of RGC apoptosis in vivo. Full characterization of probe performance in this setting creates an important in vivo imaging standard for functional evaluation of future probe analogues and provides a basis for extending this strategy into glaucoma-specific animal models.
format Article
id doaj-art-114ad8cb7a974869a1561cd5ed9c0868
institution DOAJ
issn 1932-6203
language English
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-114ad8cb7a974869a1561cd5ed9c08682025-08-20T03:11:55ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0192e8885510.1371/journal.pone.0088855Single-cell resolution imaging of retinal ganglion cell apoptosis in vivo using a cell-penetrating caspase-activatable peptide probe.Xudong QiuJames R JohnsonBradley S WilsonSeth T GammonDavid Piwnica-WormsEdward M BarnettPeptide probes for imaging retinal ganglion cell (RGC) apoptosis consist of a cell-penetrating peptide targeting moiety and a fluorophore-quencher pair flanking an effector caspase consensus sequence. Using ex vivo fluorescence imaging, we previously validated the capacity of these probes to identify apoptotic RGCs in cell culture and in an in vivo rat model of N-methyl- D-aspartate (NMDA)-induced neurotoxicity. Herein, using TcapQ488, a new probe designed and synthesized for compatibility with clinically-relevant imaging instruments, and real time imaging of a live rat RGC degeneration model, we fully characterized time- and dose-dependent probe activation, signal-to-noise ratios, and probe safety profiles in vivo. Adult rats received intravitreal injections of four NMDA concentrations followed by varying TcapQ488 doses. Fluorescence fundus imaging was performed sequentially in vivo using a confocal scanning laser ophthalmoscope and individual RGCs displaying activated probe were counted and analyzed. Rats also underwent electroretinography following intravitreal injection of probe. In vivo fluorescence fundus imaging revealed distinct single-cell probe activation as an indicator of RGC apoptosis induced by intravitreal NMDA injection that corresponded to the identical cells observed in retinal flat mounts of the same eye. Peak activation of probe in vivo was detected 12 hours post probe injection. Detectable fluorescent RGCs increased with increasing NMDA concentration; sensitivity of detection generally increased with increasing TcapQ488 dose until saturating at 0.387 nmol. Electroretinography following intravitreal injections of TcapQ488 showed no significant difference compared with control injections. We optimized the signal-to-noise ratio of a caspase-activatable cell penetrating peptide probe for quantitative non-invasive detection of RGC apoptosis in vivo. Full characterization of probe performance in this setting creates an important in vivo imaging standard for functional evaluation of future probe analogues and provides a basis for extending this strategy into glaucoma-specific animal models.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0088855&type=printable
spellingShingle Xudong Qiu
James R Johnson
Bradley S Wilson
Seth T Gammon
David Piwnica-Worms
Edward M Barnett
Single-cell resolution imaging of retinal ganglion cell apoptosis in vivo using a cell-penetrating caspase-activatable peptide probe.
PLoS ONE
title Single-cell resolution imaging of retinal ganglion cell apoptosis in vivo using a cell-penetrating caspase-activatable peptide probe.
title_full Single-cell resolution imaging of retinal ganglion cell apoptosis in vivo using a cell-penetrating caspase-activatable peptide probe.
title_fullStr Single-cell resolution imaging of retinal ganglion cell apoptosis in vivo using a cell-penetrating caspase-activatable peptide probe.
title_full_unstemmed Single-cell resolution imaging of retinal ganglion cell apoptosis in vivo using a cell-penetrating caspase-activatable peptide probe.
title_short Single-cell resolution imaging of retinal ganglion cell apoptosis in vivo using a cell-penetrating caspase-activatable peptide probe.
title_sort single cell resolution imaging of retinal ganglion cell apoptosis in vivo using a cell penetrating caspase activatable peptide probe
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0088855&type=printable
work_keys_str_mv AT xudongqiu singlecellresolutionimagingofretinalganglioncellapoptosisinvivousingacellpenetratingcaspaseactivatablepeptideprobe
AT jamesrjohnson singlecellresolutionimagingofretinalganglioncellapoptosisinvivousingacellpenetratingcaspaseactivatablepeptideprobe
AT bradleyswilson singlecellresolutionimagingofretinalganglioncellapoptosisinvivousingacellpenetratingcaspaseactivatablepeptideprobe
AT sethtgammon singlecellresolutionimagingofretinalganglioncellapoptosisinvivousingacellpenetratingcaspaseactivatablepeptideprobe
AT davidpiwnicaworms singlecellresolutionimagingofretinalganglioncellapoptosisinvivousingacellpenetratingcaspaseactivatablepeptideprobe
AT edwardmbarnett singlecellresolutionimagingofretinalganglioncellapoptosisinvivousingacellpenetratingcaspaseactivatablepeptideprobe